Fund Details
ICICI Prudential Ultra Short Term Fund Direct Growth
| Risk | Moderate |
|---|---|
| Min SIP Amount | ₹1000 |
| Expense Ratio | 0.39% |
| NAV | ₹22.53 (25 Nov 2020) |
|---|---|
| Fund Started | 10 Jan 2013 |
| Fund Size | ₹8,266 Cr |
Returns
as per Historical Returns
Comparison
1. Lower expense ratio - 0.39%
2. Exit load is zero
3. 1Y Returns are higher than the category average returns
4. 3Y Returns are higher than the category average returns
5. 5Y Returns are higher than the category average returns
Found nothing so far.
Top Holdings
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| Reserve Bank of India | Financial | T-Bills | 3.6% |
| REC Ltd. | Financial | Bonds/Deb | 3.5% |
| Sikka Ports and Terminals Ltd. | Energy | Debenture | 2.6% |
| Manappuram Finance Ltd. | Financial | NCD | 2.5% |
| Reliance Industries Ltd. | Energy | CP | 2.4% |
| Housing Development Finance Corpn. Ltd. | Financial | Debenture | 1.9% |
| Tata Value Homes Ltd. | Financial | NCD | 1.8% |
| Housing Development Finance Corpn. Ltd. | Financial | Debenture | 1.8% |
| Motilal Oswal Home Finance Ltd. | Financial | NCD | 1.8% |
| AU Small Finance Bank Ltd. | Financial | CD | 1.8% |
Fund Managers
ICICI Prudential Ultra Short Term Fund Direct Growth Details
ICICI Prudential Ultra Short Term Fund Direct Growth is a Debt Mutual Fund Scheme launched by ICICI Prudential Mutual Fund. This scheme was made available to investors on 10 Jan 2013. Rajat Chandak, Manish Banthia, Ritesh Lunawat is the Current Fund Manager of ICICI Prudential Ultra Short Term Fund Direct Growth fund.The fund currently has an Asset Under Management(AUM) of ₹8,266 Cr and the Latest NAV as of 25 Nov 2020 is ₹22.53.
The ICICI Prudential Ultra Short Term Fund Direct Growth is rated Moderate risk. Minimum SIP Investment is set to 1000. Minimum Lumpsum Investment is 5000.
Investment Objective
The scheme seeks to generate income through investments in a range of debt and money market instruments.
Tax Implications
Returns are taxed as per your Income Tax slab, if sold before 3 years. Negligible Tax (20% with indexation benefit) post 3 years.
